GSK once again tops drug accessibility ranking, with J&J and AstraZeneca close behind
Will the pandemic be a turning point for drug and vaccine access around the world? That depends on pharma’s next steps, according to the latest biennial report by the Access to Medicine Foundation.
The Bill and Melinda Gates Foundation-backed group noted “industry-wide” progress since its last report, led by GSK, which kept its first-place accessibility ranking for the eighth time. However, the foundation also reported that low-income countries remain “widely overlooked,” and many dangerous diseases are going unaddressed.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.